Related Experiment Video
Updated: Jan 27, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
Host-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers in Plasma
Julio Alonso-Padilla1, Dolors Tassies2, Nuria Cortes-Serra1
1Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Insights
Diagnosing chronic Chagas disease (Chagas disease) is challenging. New methods measuring host molecules, like thrombin generation, may track treatment effectiveness for Trypanosoma cruzi infections.
Area of Science:
- * Parasitology and Tropical Medicine
- * Cardiovascular and Gastrointestinal Pathology
- * Biochemistry and Molecular Diagnostics
Background:
- * Chagas disease, caused by Trypanosoma cruzi, affects ~30% of chronically infected individuals, leading to severe cardiac and gastrointestinal complications.
- * Current diagnostic methods often identify the infection late, after clinical symptoms manifest, hindering timely intervention.
- * Existing treatments for Chagas disease lack effective diagnostics to monitor therapeutic response, delaying assessment of efficacy.
Purpose of the Study:
- * To introduce novel diagnostic procedures for assessing therapeutic response in chronic Chagas disease.
- * To measure host-derived molecules as surrogates for evaluating treatment efficacy against Trypanosoma cruzi infection.
- * To investigate the role of thrombin generation as a biomarker for treatment response.
Main Methods:
- * Development and validation of two procedures to quantify host-derived molecules.
- * Focus on measuring thrombin generation, a key indicator of the blood coagulation cascade.
- * Assessment of thrombin generation in relation to hypercoagulability in Chagas disease patients.
Main Results:
- * The proposed procedures measure host-derived molecules linked to thrombin generation and coagulation.
- * A hypercoagulable state is characteristic of chronic Chagas disease.
- * This hypercoagulability state is observed to revert following treatment with benznidazole.
Conclusions:
- * Measuring thrombin generation offers a viable surrogate for assessing therapeutic response in chronic Chagas disease.
- * These host-derived biomarkers can facilitate timely evaluation of treatment efficacy.
- * The findings support the use of coagulation markers for monitoring Chagas disease treatment outcomes.
Abstract:
The most severe clinical symptomatology of Chagas disease affects ~30% of those chronically infected with the Trypanosoma cruzi parasite. The pathogenic mechanisms that lead to life-threatening heart and gut tissue disruptions occur "silently" for a longtime in a majority of cases. As a result, despite there are several serological and molecular methods available to diagnose the infection in its acute and chronic stages, diagnosis is often achieved only after the onset of clinical symptoms in the chronic phase of the disease. Furthermore, although there are two drugs to treat it, the assessment of their performance is impractical with current parasite-derived diagnostics, and therapeutic efficacy cannot be acknowledged in a timely manner.In this chapter we present two procedures to measure host-derived molecules as surrogates of therapeutic response against chronic T. cruzi infection. Their outputs relate to the generation and activity of thrombin, a major component of the blood coagulation cascade. This is due to the fact that a hypercoagulability state has been described to occur in chronic Chagas disease patients and revert after treatment with benznidazole.
Related Concept Videos
Molecules and Compounds
Composition of Blood Plasma
Plasma Membrane in Bacteria and Archaea
Enlargement of the Plasma Membrane
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Measurement: Derived Units

